Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Harvard Business School
McKinsey
Fuji
Boehringer Ingelheim
Fish and Richardson
Covington
Argus Health

Generated: June 23, 2018

DrugPatentWatch Database Preview

VAGISTAT-1 Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Vagistat-1 patents expire, and when can generic versions of Vagistat-1 launch?

Vagistat-1 is a drug marketed by Combe and is included in one NDA.

The generic ingredient in VAGISTAT-1 is tioconazole. There are three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the tioconazole profile page.
Summary for VAGISTAT-1
Drug patent expirations by year for VAGISTAT-1
Synonyms for VAGISTAT-1
(.+/-.)-1-(2,4-Dichloro-.beta.-((2-chloro-3-ethenyl)oxy)phenethyl)imidazole
(.+/-.)-Tioconazole
(+-)-1-(2 4-Dichloro-beta-((2-chloro-3-ethenyl)oxy)phenethyl)imidazole
(+-)-1-(2,4-Dichloro-beta-((2-chloro-3-ethenyl)oxy)phenethyl)imidazole
(+-)-1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
(+-)-Tioconazole
1-(2-((2-chlorothiophen-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole
1-(2,4-Dichloro-(beta-(2-chloro-3-thenyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2-chloro-3-thenyl)-oxy)phenethyl)imidazole
1-[2-[(2-chloranylthiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole
1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole #
1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole
1-[2-[(2-chloro-3-thiophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole
1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)-ethyl]imidazole
1-[2-[(2-Chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)-ethyl]imidazole; Vagistat
1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole
1-[2,4-Dichloro-.beta.-[(2-chloro-3-thenyl)-oxy]phenethyl]imidazole
1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole
1-{2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
144025-07-0
1H-Imidazole, 1-(2-((2-chloro-3-thienyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-
1H-Imidazole, 1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-
5-23-04-00324 (Beilstein Handbook Reference)
65899-73-2
899T732
A835270
AB0013379
AB01275523_02
AB01275523_03
AB01275523-01
AB2000368
AC-13425
AC1L1KG2
AKOS015906500
Ambap65899-73-2
AN-38523
API0004425
BDBM50370218
BG0341
BRN 0573867
C-21484
C08082
C16H13Cl3N2OS
CAS-65899-73-2
CC-35071
CCG-213487
CHEBI:77898
CHEMBL1200438
CS-2360
CTK8G3486
D00890
D0CA6J
DB01007
DL-515
DR002227
DSSTox_CID_26619
DSSTox_GSID_46619
DSSTox_RID_81771
DTXSID3046619
EBD39607
EINECS 265-973-8
FT-0630756
Fungibacid
GA0099
GyneCure
Gyno-trosyd
H949
HE376393
HMS2090B12
HMS2093P11
HMS3655K22
HY-B0319
KM0968
KS-00001F6X
KS-5114
LS-78340
MFCD00057276
MLS003899209
MLS004712040
MLS006010907
MolPort-003-666-711
Monistat 1
NCGC00167430-01
NCGC00167430-02
NCGC00167430-03
NCGC00167430-04
New Straitus
NSC-759169
NSC759169
Pharmakon1600-01505581
QXHHHPZILQDDPS-UHFFFAOYSA-N
s1910
SBI-0206824.P001
SCHEMBL41354
SMR001550005
SR-05000001939
SR-05000001939-2
Thioconazole
Tioconazol
Tioconazol [INN-Spanish]
tioconazole
Tioconazole (JAN/USP/INN)
Tioconazole [USAN:BAN:INN:JAN]
Tioconazole [USAN:USP:INN:BAN:JAN]
Tioconazole for system suitability, European Pharmacopoeia (EP) Reference Standard
Tioconazole, 97%
Tioconazole, United States Pharmacopeia (USP) Reference Standard
Tioconazole, VETRANAL(TM), analytical standard
Tioconazolum
Tioconazolum [INN-Latin]
Tox21_112434
Tox21_112434_1
trosid
Trosyd
Trosyd AF
Trosyd J
Trosyl
Tz-3
UK 20,349
UK 20349
UK-20,349
UK-20349
Vagistat
Vagistat-1 (TN)
Zoniden

US Patents and Regulatory Information for VAGISTAT-1

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Combe VAGISTAT-1 tioconazole OINTMENT;VAGINAL 020676-001 Feb 11, 1997 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
McKesson
Deloitte
Johnson and Johnson
Cerilliant
Baxter
Cipla
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.